The Anodyne® Therapy System was the first infrared light therapy product cleared by the FDA in 1994, and it remains one of the few evidence based infrared light therapy modalities on the market today.
Many manufacturers reference clinical data completed using other light therapy products - and have little to no proprietary clinical data on their specific devices.
There are 19 published peer reviewed studies demonstrating the exceptional outcomes with Anodyne® Therapy Systems.
Throughout these studies, the term MIRE™ is also referenced. This term represents the words Monochromatic Infrared Energy and is a trademark of Anodyne® Therapy technology specifically.
These clinical studies have been published in such journals as Diabetes Care, Practical Pain Management, Age and Ageing and Endocrine Practice.